BACKGROUND: The expression of calcium/calmodulin-dependent kinase IV (CaMKIV) was hitherto thought to be confined to the nervous system. However, a recent genome-wide analysis indicated an association between hypertension and a single-nucleotide polymorphism (rs10491334) of the human CaMKIV gene (CaMK4), which suggests a role for this kinase in the regulation of vascular tone. METHODS AND RESULTS: To directly assess the role of CaMKIV in hypertension, we characterized the cardiovascular phenotype of CaMK4(-/-) mice. They displayed a typical hypertensive phenotype, including high blood pressure levels, cardiac hypertrophy, vascular and kidney damage, and reduced tolerance to chronic ischemia and myocardial infarction compared with wild-type littermates. Interestingly, in vitro experiments showed the ability of this kinase to activate endothelial nitric oxide synthase. Eventually, in a population study, we found that the rs10491334 variant associates with a reduction in the expression levels of CaMKIV in lymphocytes from hypertensive patients. CONCLUSIONS: Taken together, our results provide evidence that CaMKIV plays a pivotal role in blood pressure regulation through the control of endothelial nitric oxide synthase activity
CaMK4 Gene Deletion Induces Hypertension / G. Santulli, E. Cipolletta, D. Sorriento, C. Del Giudice, A. Anastasio, S. Monaco, A.S. Maione, G. Condorelli, A. Puca, B. Trimarco, M. Illario, G. Iaccarino. - In: JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE. - ISSN 2047-9980. - 1:4(2012 Aug), pp. e001081.e001081-e001081.e001081.
|Titolo:||CaMK4 Gene Deletion Induces Hypertension|
|Parole Chiave:||angiogenesis ; arrhythmia ; endothelium ; hypertension ; hypertrophy|
|Settore Scientifico Disciplinare:||Settore MED/11 - Malattie dell'Apparato Cardiovascolare|
|Data di pubblicazione:||ago-2012|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1161/JAHA.112.001081|
|Appare nelle tipologie:||01 - Articolo su periodico|